These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1307207)

  • 1. [Colon adenocarcinoma with neuroendocrine and squamous cell differentiation. A case report].
    Santos GC; Zucoloto S; Coelho KI; Schmitt FC
    Arq Gastroenterol; 1992; 29(2):62-5. PubMed ID: 1307207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenocarcinoma of the colon with neuroendocrine features and secretory diarrhea.
    Lew EA; Lewin KJ; Zarchy T; Pisegna JR
    Am J Gastroenterol; 1999 Jun; 94(6):1692-4. PubMed ID: 10364049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of neuroendocrine markers: a signature of human undifferentiated carcinoma of the colon and rectum.
    Grabowski P; Schönfelder J; Ahnert-Hilger G; Foss HD; Heine B; Schindler I; Stein H; Berger G; Zeitz M; Scherübl H
    Virchows Arch; 2002 Sep; 441(3):256-63. PubMed ID: 12242522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroendocrine differentiation of periodic-acid Schiff and Alcian blue-negative signet-ring cell-like cells and tubular adenocarcinoma cells within a gastric cancer.
    Sugihara A; Nakasho K; Yamada N; Nakagomi N; Tsujimura T; Terada N; Tsuji M
    Scand J Gastroenterol; 2004 Aug; 39(8):795-800. PubMed ID: 15513370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bcl-2 protein expression in lung cancer and close correlation with neuroendocrine differentiation.
    Jiang SX; Kameya T; Sato Y; Yanase N; Yoshimura H; Kodama T
    Am J Pathol; 1996 Mar; 148(3):837-46. PubMed ID: 8774138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroendocrine differentiation in colorectal carcinomas.
    Syversen U; Halvorsen T; Mårvik R; Waldum HL
    Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):667-74. PubMed ID: 8590163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and prognostic significance of neuroendocrine cells in esophageal adenocarcinoma.
    Hamilton K; Chiappori A; Olson S; Sawyers J; Johnson D; Washington K
    Mod Pathol; 2000 May; 13(5):475-81. PubMed ID: 10824917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroendocrine differentiation in prostatic carcinomas. A retrospective autopsy study.
    Turbat-Herrera EA; Herrera GA; Gore I; Lott RL; Grizzle WE; Bonnin JM
    Arch Pathol Lab Med; 1988 Nov; 112(11):1100-5. PubMed ID: 2460064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The frequency and clinical significance of neuroendocrine cells within stage III adenocarcinomas of the colon.
    Foley EF; Gaffey MJ; Frierson HF
    Arch Pathol Lab Med; 1998 Oct; 122(10):912-4. PubMed ID: 9786353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shadow cell differentiation in tumours of the colon and uterus.
    Zámecník M; Michal M
    Zentralbl Pathol; 1995 Apr; 140(6):421-6. PubMed ID: 7538784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of neuroendocrine differentiation in clinically localized prostatic carcinoma.
    Abrahamsson PA; Cockett AT; di Sant'Agnese PA
    Prostate Suppl; 1998; 8():37-42. PubMed ID: 9690662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Divergent neuroendocrine differentiation in prostatic carcinoma.
    di Sant' Agnese PA
    Semin Diagn Pathol; 2000 May; 17(2):149-61. PubMed ID: 10839615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prostatic adenocarcinoma with neuroendocrine differentiation of the small cell type].
    Rimoldi DA; Antonio Costa J; Roveto S; Rivero O
    Medicina (B Aires); 2001; 61(3):322-4. PubMed ID: 11474882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenocarcinoma with neuroendocrine differentiation of the urinary bladder. Clinicopathologic, immunohistochemical, and ultrastructural study.
    Abenoza P; Manivel C; Sibley RK
    Arch Pathol Lab Med; 1986 Nov; 110(11):1062-6. PubMed ID: 3778122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation and clinical value of neuroendocrine differentiation in human prostatic tumors.
    Cussenot O; Villette JM; Cochand-Priollet B; Berthon P
    Prostate Suppl; 1998; 8():43-51. PubMed ID: 9690663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between chromogranin-A expression and pathological variables in human colon carcinoma.
    Indinnimeo M; Cicchini C; Memeo L; Stazi A; Provenza C; Ricci F; Mingazzini PL
    Anticancer Res; 2002; 22(1A):395-8. PubMed ID: 12017321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroendocrine differentiation in stage D2 prostate cancers.
    Kamiya N; Suzuki H; Kawamura K; Imamoto T; Naya Y; Tochigi N; Kakuta Y; Yamaguchi K; Ishikura H; Ichikawa T
    Int J Urol; 2008 May; 15(5):423-8. PubMed ID: 18452460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary mesenteric malignant mixed mesodermal (müllerian) tumor with neuroendocrine differentiation.
    Cokelaere K; Michielsen P; De Vos R; Sciot R
    Mod Pathol; 2001 May; 14(5):515-20. PubMed ID: 11353063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and prognostic significance of endocrine cells in colorectal adenocarcinomas.
    Lapertosa G; Baracchini P; Delucchi F
    Pathologica; 1994 Apr; 86(2):170-3. PubMed ID: 7936761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokeratin 20-positive large cell neuroendocrine carcinoma of the colon.
    Kato T; Terashima T; Tomida S; Yamaguchi T; Kawamura H; Kimura N; Ohtani H
    Pathol Int; 2005 Aug; 55(8):524-9. PubMed ID: 15998383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.